Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Exelixis announces positive results for its drug Cabometyx in the treatment of neuroendocrine tumors

Exelixis announces positive results for its drug Cabometyx in the treatment of neuroendocrine tumors

老虎证券老虎证券2026/05/30 14:30
Show original
Data shows that this drug significantly reduced the risk of disease progression or death by 74% in patients with non-functional neuroendocrine tumors. Meanwhile, in the group of patients with functional neuroendocrine tumors, the risk reduction also reached 60%.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

SpaceX (SPCX.US) completes low-frequency spectrum allocation, targeting the entire US mobile communications market! The three major US telecom stocks plunge collectively after hours

SpaceX has reached an agreement to acquire a nationwide portfolio of low-band spectrum licenses for mobile communications, paving the way for its Starlink Mobile service to directly enter the U.S. telecommunications market.

智通财经•2026/10/08 23:32

Apple (AAPL.US) October Second Launch Event Incoming! First Touchscreen MacBook and New iPad mini Unveiled, M6 Chip and Smart Home Ecosystem Released Together

Apple (AAPL.US) is scheduled to launch a comprehensive new smart home strategy next week and plans to hold a second event in October to unveil its first touchscreen MacBook and the new iPad mini.

智通财经•2026/10/08 23:26